Cryptococcosis historical perspective

Revision as of 16:00, 28 December 2015 by Sergekorjian (talk | contribs)
Jump to navigation Jump to search

Cryptococcosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptococcosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptococcosis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptococcosis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptococcosis historical perspective

CDC on Cryptococcosis historical perspective

Cryptococcosis historical perspective in the news

Blogs on Cryptococcosis historical perspective

Directions to Hospitals Treating Cryptococcosis

Risk calculators and risk factors for Cryptococcosis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Serge Korjian M.D.; Yazan Daaboul, M.D.

Overview

Cryptococci, initially thought to be of the Saccharomyces genus, were first identified in 1894 by German pathologist Otto Busse in a patient with chronic periostitis of the tibia. In 1901, Jean Paul Vuillemin, a French mycologist, transferred the yeast-like fungus to the genus Cryptococcus due to the absence of ascospores in its life cycle, a defining feature of Saccharomyces.[1][2]

Historical Perspective

  • Cryptococci were first identified in 1894 by German pathologist Otto Busse in a patient with chronic periostitis of the tibia. He described the isolated organism as a "Saccharomyces-like" pathogen.[2]
  • The infection was referred to as "Busse-Buschke" disease named after Busse and his colleague, dermatologist Abraham Buschke.[3]
  • Busse later named the organism Saccharomyces hominis.
  • During the same time period, Francesco Sanfelice reported isolating a similar organism from fermenting peach juice. Due to its unique colony form, he refered to the species as Saccharomyces neoformans.
  • In 1901, Jean Paul Vuillemin, a French mycologist, transferred the yeast-like fungus to the genus Cryptococcus due to the absence of ascospores in its life cycle, a defining feature of Saccharomyces.[1]
  • In the 1950s, four capsule serotypes (A through D) were identified using rabbit antisera. This classification was later improved upon by DNA sequencing, epidemiology, and pathobiology.[2][4]
  • Until 1999, Cryptococcus gattii was known as Cryptococcus neoformans var gattii, until it was recognized as separate species with distinct epidemiological patterns and clinical manifestations.[5]

References

  1. 1.0 1.1 Kurtzman CP, Fell JW, Boekhout T. The Yeasts, A Taxonomic Study. 2011
  2. 2.0 2.1 2.2 Srikanta D, Santiago-Tirado FH, Doering TL (2014). "Cryptococcus neoformans: historical curiosity to modern pathogen". Yeast. 31 (2): 47–60. doi:10.1002/yea.2997. PMC 3938112. PMID 24375706.
  3. Knoke M, Schwesinger G (1994). "One hundred years ago: the history of cryptococcosis in Greifswald. Medical mycology in the nineteenth century". Mycoses. 37 (7–8): 229–33. PMID 7739651.
  4. EVANS EE (1950). "The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions". J Immunol. 64 (5): 423–30. PMID 15415610.
  5. Rolston KV (2013). "Cryptococcosis due to Cryptococcus gattii". Clin Infect Dis. 57 (4): 552–4. doi:10.1093/cid/cit342. PMID 23697746.